David Silbersweig

David Alan Silbersweig is an American psychiatrist and neurologist who serves as Chairman Emeritus of the Department of Psychiatry at Brigham and Women's Hospital and Stanley Cobb Professor of Psychiatry at Harvard Medical School. He is recognized as one of the pioneers of functional neuroimaging research in psychiatry and a leading figure in the development of the field of neuropsychiatry.

Silbersweig's research has focused on developing and applying advanced neuroimaging techniques to understand brain circuitry dysfunction underlying major psychiatric disorders. His landmark studies include the first functional neuroimaging localization of hallucinations in schizophrenia and tics in Tourette syndrome, as well as groundbreaking work identifying neural mechanisms of emotional dysregulation in borderline personality disorder.

Background Silbersweig graduated from Dartmouth College with high honors in philosophy. He received his medical degree from Cornell University Medical College. He completed combined residency training in both psychiatry and neurology at The New York Presbyterian Hospital-Weill Cornell Medical Center, making him dually board-certified in both specialties.

During the early 1990s, Silbersweig conducted research training in the emerging field of functional brain imaging at the Medical Research Council Cyclotron Unit, Hammersmith Hospital in London, where he worked with colleagues to develop novel positron emission tomography (PET) imaging methods that would later prove instrumental in his landmark neuropsychiatric studies.

Career After completing his training, Silbersweig returned to Cornell where he founded and directed the Functional Neuroimaging Laboratory with Dr. Emily Stern. At Cornell, he also served as founding Director of the Division of Neuropsychiatry and founding Director of the Neurology-Psychiatry Combined Residency Program, helping to establish neuropsychiatry as a distinct clinical and research discipline. He held the position of Stephen P. Tobin and Dr. Arnold M. Cooper Professor of Psychiatry, and served as Professor of Neurology and Neurosciences, as well as Vice Chairman for Research in the Department of Psychiatry.

In the early 2010s, Silbersweig moved to Harvard Medical School and Brigham and Women's Hospital, where he served as Chairman of the Department of Psychiatry and Co-Director of the Brigham and Women's Hospital Institute for the Neurosciences. He currently holds the position of Stanley Cobb Professor of Psychiatry at Harvard Medical School and serves as Chairman Emeritus of the Department of Psychiatry at Brigham and Women's Hospital.

Scholarly work Silbersweig is known for his pioneering contributions to functional neuroimaging research in psychiatry.

Hallucinations in schizophrenia In 1995, Silbersweig and colleagues published a landmark study in Nature that, for the first time, used functional neuroimaging to localize brain activity specifically associated with hallucinations in patients with schizophrenia. The research employed innovative event-related PET methods, with patients signaling when they were experiencing hallucinations so that imaging could capture the precise brain states during these phenomena.

The study revealed that auditory verbal hallucinations were associated with activity in subcortical nuclei including the thalamus and striatum, limbic structures especially the hippocampus, and paralimbic regions including the parahippocampal and cingulate gyri as well as orbitofrontal cortex. In one unique patient experiencing both visual and auditory hallucinations, the team demonstrated activation in visual and auditory/linguistic association cortices as part of a distributed cortical-subcortical network. The findings suggested that activity in deep brain structures may generate or modulate hallucinations, while the specific neocortical regions activated determine the particular perceptual content experienced by individual patients.

Depression and other psychiatric disorders Silbersweig's laboratory has also contributed to understanding neural mechanisms in depression, post-traumatic stress disorder (PTSD), and other conditions across the neuropsychiatric spectrum. A focus has been on characterizing fronto-limbic modulation abnormalities that may represent common neural pathways underlying different psychiatric clinical phenotypes. The overarching goal of this systems-level neuropathophysiology work is to provide a foundation for developing novel, targeted, biologically-based diagnostic and therapeutic strategies.

Leadership and professional activities Beyond his research contributions, Silbersweig has played a significant role in shaping the field of neuropsychiatry through educational and organizational activities. He was the founding Vice Chairman of the Governing Board of the National Network of Depression Centers and has been involved in leadership roles in national and international research consortia.

Silbersweig is a fellow of the American Neuropsychiatric Association and has served in leadership positions within the organization. He has contributed to major textbooks in neuropsychiatry and serves on the editorial boards of leading scientific journals. His work with the main journal in the field of neuropsychiatry, prominent continuing medical education courses, and numerous invited presentations at national and international conferences have helped establish standards and advance knowledge in the discipline.

Impact and legacy Silbersweig's pioneering work in functional neuroimaging has helped establish the biological foundations of major psychiatric symptoms and disorders. His studies demonstrating objective brain abnormalities underlying hallucinations, tics, and emotional dysregulation have contributed to reducing stigma associated with mental illness by showing that psychiatric patients suffer from measurable brain dysfunction analogous to neurological conditions.

The innovative imaging methods and paradigms developed by his laboratory have been widely adopted and have enabled subsequent generations of neuropsychiatric research. His work continues to inform the development of circuit-based approaches to psychiatric diagnosis and treatment, with potential implications for more precise and effective therapeutic interventions.